Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHYSACTO: Tiotropium + Olodaterol and Exercise in COPD
NCT02085161Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of tiotropium, olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Mar 2014; status: completed.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02085161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085161.